These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24034056)

  • 41. Living-donor kidney transplant from a type a donor to a type a subgroup recipient.
    Ueda N; Nishimura K; Yoshida Y; Hirai T; Kishikawa H; Ichikawa Y
    Exp Clin Transplant; 2015 Apr; 13(2):193-5. PubMed ID: 25078093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isoagglutinin adsorption in ABO-incompatible transplantation.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of progressive thrombotic microangiopathy after ABO-incompatible renal transplantation.
    Miura M; Fujita H; Suzuki A; Kubota KC; Fukasawa Y; Shimoda N; Tsuchihashi S; Tamaki T
    Clin Transplant; 2011 Jul; 25 Suppl 23():19-22. PubMed ID: 21623909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
    Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
    Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ABO incompatible renal transplantation in an HIV-seropositive patient.
    Campara M; West-Thielke P; Thielke J; Ommert T; Oberholzer J; Benedetti E; Kaplan B
    Transplantation; 2008 Jul; 86(1):176-8. PubMed ID: 18622297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.
    Hazzan M; Labalette M; Copin MC; Glowacki F; Provôt F; Pruv FR; Noël C
    J Am Soc Nephrol; 2005 Aug; 16(8):2509-16. PubMed ID: 15987748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange.
    Kawagishi N; Satoh K; Enomoto Y; Akamatsu Y; Sekiguchi S; Fukumori T; Fujimori K; Satomi S
    Transplant Proc; 2005 Mar; 37(2):1205-6. PubMed ID: 15848670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
    Smak Gregoor PJ; van Gelder T; van Besouw NM; van der Mast BJ; IJzermans JN; Weimar W
    Transplantation; 2000 Jul; 70(1):143-8. PubMed ID: 10919591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kidney transplantation of living unrelated and ABO-incompatible donor-recipient combinations.
    Ishikawa N; Yagisawa T; Kimura T; Sakuma Y; Fujiwara T; Nukui A; Yashi M
    Transplant Proc; 2013 Apr; 45(3):1242-4. PubMed ID: 23622668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.
    Hatakeyama S; Fujita T; Murakami R; Suzuki Y; Sugiyama N; Yamamoto H; Okamoto A; Imai A; Tobisawa Y; Yoneyama T; Mori K; Yoneyama T; Hashimoto Y; Koie T; Narumi S; Ohyama C
    Transplant Proc; 2014; 46(2):445-8. PubMed ID: 24655984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of positive PRA on the results of ABO-incompatible kidney transplantation.
    Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Toma H
    Transplant Proc; 2004 Sep; 36(7):2169-71. PubMed ID: 15518789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
    Wong W; Tolkoff-Rubin N; Delmonico FL; Cardarelli F; Saidman SL; Farrell ML; Shih V; Winkelmayer WC; Cosimi AB; Pascual M
    Clin Transplant; 2004 Aug; 18(4):341-8. PubMed ID: 15233807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.
    Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Teraoka S; Toma H
    Transplant Proc; 2004 Sep; 36(7):2172-4. PubMed ID: 15518790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S; Daswani A; Takemoto SK
    Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kidney transplantation of living unrelated donor-recipient combinations.
    Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Kimura T; Nukui A; Yashi M
    Transplant Proc; 2012 Jan; 44(1):254-6. PubMed ID: 22310625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial.
    Åsberg A; Apeland T; Reisaeter AV; Foss A; Leivestad T; Heldal K; Thorud LO; Eriksen BO; Hartmann A;
    Clin Transplant; 2013; 27(2):E151-6. PubMed ID: 23351013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D; Del Carmen Rial M; Vitko S; del Castillo D; Manas D; Lao M; Gafner N; Wijngaard P;
    J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Japan's experience with living-donor kidney transplantation across ABO barriers.
    Ichimaru N; Takahara S
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):682-92. PubMed ID: 18941430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ABO-incompatible kidney transplantation of an 8-yr-old girl with donor/recipient-constellation A1B/B.
    Ahlenstiel T; Offner G; Strehlau J; Pape L; Froede K; Ehrich JH; Schwarz A; Heuft HG; Klempnauer J
    Xenotransplantation; 2006 Mar; 13(2):141-7. PubMed ID: 16623809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.